A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer

NCT03789604 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

479

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

BIOLOGICAL: CS1001 monoclonal antibody
BIOLOGICAL: CS1001 placebo

Sponsor

CStone Pharmaceuticals